Chemelot Ventures
VC Fund
Urmond, The Netherlands
Chemelot Ventures is an active regional venture capital investor in materials and life sciences in the south of The Netherlands. They have a strong focus on value enhancement of their portfolio companies by using their network and the network of their LP's, DSM Nederland, Limburg Province, regional development agency LIOF and Rabobank.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 50%
- Fund size:
- $20M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Chemelot Ventures invests in
Stages Chemelot Ventures invests in
Countries Chemelot Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
Investment Focus
Industry
- Biotechnology 7 (44%)
- Medical 5 (31%)
- Health Care 4 (25%)
- Life Science 3 (19%)
- Manufacturing 3 (19%)
Stage
- Funding Round 9 (56%)
- Series A 4 (25%)
- Seed 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Casper Bruens
Director
|
Director | Total investments: 0 | Find email | |
|
Marcel Kloosterman
Senior Investment Manager
|
Senior Investment Manager | Total investments: 6 | Find email | |
|
Patrick Claessen
Senior Investment Manager
|
Senior Investment Manager | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets. | $1.1M / Seed / Aug 28, 2023 | |
|
|
Carbon black is a form of elemental carbon that is manufactured by the controlled vapour-phase pyrolysis and partial combustion of hydrocarbons. Several processes have been used to produce carbon black, including the oil-furnace, impingement (channel), lampblack, thermal (decomposition of natural gas) and acetylene (decomposition) processes.Carbon blacks are commonly referred to by the process or the source material from which they are made, e.g. furnace black, lampblack, thermal black, acetylene black and channel black. The different grades from the various processes have certain unique characteristics, but it is now possible to produce reasonable approximations of most of these grades using the oil-furnace process, by which more than 95% of the total output of carbon black is produced. | $12.1M / Sep 07, 2018 | |
|
|
Health Value Creation is developing two surgical devices, a diagnostic tool and a trocar closure device. The first device helps prevent anastomotic leakages after bowel surgery by predicting the quality of the anastomosis during surgery, thereby reducing post-operative complications and lowering healthcare costs. The second device is a trocarclosure device for faster, safer and more secure suturing after laparoscopic surgery, resulting in a reduction of the chances of wound herniation. | $2.2M / Series A / Dec 22, 2017 | |
|
|
Mito Medical is developing an innovative diagnostic device that measures vascularity (blood-vessel formation) in the breast and aims to replace the often harmful X-ray cancer screening examination. This technology enables pain-free breast cancer screening with no adverse health risks in both younger and older women, at an earlier stage than iscurrently the case. | Oct 24, 2017 | |
|
|
TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms. | $2.2M / Series A / Sep 18, 2017 | |
|
|
Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles as well as their downstream dispersions and functional coating products thereof. Coatings play an important role in our everyday life, although often not recognized by those who do not master the art. Coatings are a big market and many products fallunder this category. Kriya Materials focuses itself on the development and manufacturing of various nano metal oxides which it uses internally for the development and production of very high end coatings.The coatings made by Kriya Materials are applied in a wide range of markets, some examples are the Plasma Panel and LCD industry, from Smartphone to touch panels to glass surfaces. | $3.3M / Series A / Sep 13, 2017 | |
|
|
Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. It aims to find valuable solutions for medical needs by creating superior drug products. Both new and existing drugs can be combined with Cristal Therapeutics Polymeric Technologies, shortly abbreviated as CriPec.CriPec-based products are versatile as a crystal and allow to improve the treatment of various diseases. | $13.6M / Jan 19, 2017 | |
|
|
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies to treat disorders that are associated with fulminant inflammation such as sepsis. The most advanced product in development is the heparin fraction M6229 for the treatment of severe sepsis and septic shock. | $2.1M / Nov 17, 2016 | |
|
|
Fortimedix is a global leader in the field of endovascular stents. With full in-house stent development and manufacturing capabilities, they have been a trusted partner for over 15 years.As a leader in stent technology, they invest heavily in research & development which fosters innovation, enables continuous improvement, and fulfils theirdedication to operational excellence.At Fortimedix everything they do is inspired by their Mission and Vision. It is of great importance to us that their customers, employees and stakeholders know what they stand for and where they are going. | $12.1M / Series A / Oct 12, 2016 | |
|
|
Materiomics BV is a biotech company located in Enschede, The Netherlands. The company has developed TopoChip. Materiomics BV designs and identifies the best surface for improved functionality and durability of medical and cell culture devices. | $1.5M / Nov 13, 2015 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Chemelot Ventures invest in?
Chemelot Ventures invests primarily in Biotechnology, Medical and Health Care startups, most often at Funding Round and Series A stage. Most of the 16 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chemelot Ventures?
Public channels for Chemelot Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Chemelot Ventures?
The team at Chemelot Ventures includes Casper Bruens (Director), Marcel Kloosterman (Senior Investment Manager) and Patrick Claessen (Senior Investment Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!